CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?Zacks Investment Research • 03/19/25
CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)Seeking Alpha • 03/03/25
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.The Motley Fool • 02/28/25
CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care ConferenceGlobeNewsWire • 02/26/25
2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall StreetThe Motley Fool • 02/24/25
Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The FutureSeeking Alpha • 02/13/25
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 02/11/25
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewsWire • 02/11/25
CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?Zacks Investment Research • 02/07/25
CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)Seeking Alpha • 02/05/25
CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?Zacks Investment Research • 01/23/25
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?Zacks Investment Research • 01/17/25